Chu Dijon Bourgogne
Dijon, 21000, France
NCT Number: NCT05246540
Giant cell arteritis (GCA) is the most common vasculitis in adults. The diagnosis of GCA is evoked by the association of clinical signs and biological anomalies (inflammatory syndrome) in patients over 50 years of age. On the other hand, starting a treatment implies being certain of the diagnosis which requires performing a temporal artery biopsy under local anesthesia. This examination is therefore an invasive procedure for patients whose sensitivity is not optimal. This is why imaging techniques (echo-Doppler or MRI of the temporal arteries) have been developed to look for signs of vasculitis without the need to perform a biopsy. However, these examinations lack sensitivity (=falsely concluding the absence of GCA) and specificity (=falsely concluding the presence of GCA). Recently, advances in imaging, and in particular positron emission tomography (PET), have made it possible to visualize the cephalic arteries, including the temporal artery.
The aim of this study is therefore to evaluate the sensitivity and specificity of PET of the cephalic arteries for the diagnosis of GCA and to compare them with those of echo-Doppler and MRI of the temporal arteries.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Dijon, 21000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Data collection
Time frame: 6 months
diagnosis retained by the clinician without question after 6 months of follow-up and treatment for at least 6 consecutive months
Centre Hospitalier Universitaire Dijon
Other
Acronym: Cervico-TEP et
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06011512
Arteritis, Autoimmune Diseases
Aalborg, North Denmark, Denmark
View Trial DetailsNCT06130540
Arteritis, Autoimmune Diseases
Boca Raton, Florida, United States
View Trial DetailsNCT05380453
Arteritis, Autoimmune Diseases
Freiburg im Breisgau, Baden-Wurttemberg, Germany
View Trial DetailsNCT03482479
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes
Boston, Massachusetts, United States
View Trial Details